IPP Bureau
Hikal posts FY23 PAT at Rs. 36 Cr
By IPP Bureau - May 30, 2023
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Jubilant Pharmova posts Q4FY23 consolidated loss at Rs. 97.84 Cr
By IPP Bureau - May 30, 2023
The company has reported total income of Rs. 1682.45 crores during the period ended March 31, 2023
NATCO records FY23 PAT at Rs. 715.3 Cr
By IPP Bureau - May 30, 2023
The increase in revenue and profits for the year was driven by business growth in the US market and growth in our subsidiaries in Canada & Brazil.
SÜDPACK Medica and Liveo Research join forces at Connect in Pharma in Geneva
By IPP Bureau - May 29, 2023
The PP-based top and bottom webs are manufactured in a unique coextrusion process
AiMeD applauds Govt. for launching 3 major Medical Device Policy & Scheme
By IPP Bureau - May 29, 2023
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
Kristin Judge Joins Emmes as Chief Growth Officer
By IPP Bureau - May 29, 2023
Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
By IPP Bureau - May 29, 2023
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Aurobindo Pharma Q4 FY23 PAT up at Rs. 506 Cr
By IPP Bureau - May 29, 2023
US formulations revenue increased by 11.6% YoY to Rs. 3,045 crore and Europe formulation revenue stood at Rs. 1,660 crore
We need to focus on quality and affordable manufacturing: Mandaviya
By IPP Bureau - May 29, 2023
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Roquette, Beren Therapeutics join forces to advance cyclodextrin technologies
By IPP Bureau - May 29, 2023
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection
By IPP Bureau - May 27, 2023
The product is expected to be launched in June 2023
Sun Pharmaceutical Industries posts Q4 FY23 consolidated PAT at Rs. 2016.78 Cr
By IPP Bureau - May 27, 2023
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
Health Minister Mandaviya inaugurates 8th International Conference on Pharma and Medical Device Sector
By IPP Bureau - May 27, 2023
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
Labindia partners with Hamilton Laboratory to launch ‘Labindia Hamilton’
By IPP Bureau - May 27, 2023
Product deliveries scheduled in Q3 of 2023
